摘要 |
The invention relates to 3-heterocyclyl indolyl compounds capable of inhi biting the interaction between p53, or variants thereof, and MDM2 and/or MDM 4, or variants thereof, respectively, said compounds having the formula (I) wherein R1, R2, R3, R4, RA, Y and Y are as defined in the specification. Due to their activity, the compounds are useful in the treatment of various dis orders and diseases mediated by the activity of MDM2 and/or MDM4, or variant s thereof, such as inflammatory or proliferative diseases or in the protecti on of cells.
|
申请人 |
NOVARTIS AG |
发明人 |
KALLEN, JORG;FURET, PASCAL;GROELL, JEAN-MARC;VAUPEL, ANDREA;MAYR, LORENZ;MASUYA, KEIICHI;HERGOVICH LISZTWAN, JOANNA;BOETTCHER, ANDREAS;BUSCHMANN, NICOLE |